deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT04738162

Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Sponsor: Universität Münster

Updated 8 times since 2021 Last updated: Dec 9, 2025 Started: Sep 25, 2020 Primary completion: Nov 24, 2025 Completion: Nov 24, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Brain Tumor, Pediatric, this trial is completed. The trial is conducted by Universität Münster and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2021 – ~Jun 2022 · 15 months · monthly snapshotRecruiting~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshotRecruiting~Dec 2022 – ~Jan 2024 · 13 months · monthly snapshotRecruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Jan 2026 · 13 months · monthly snapshotRecruiting~Jan 2026 – present · 8 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

  2. Dec 2024 — Jan 2026 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

Show 3 earlier versions
  1. Dec 2022 — Jan 2024 [monthly]

    Recruiting PHASE2

  2. Jun 2022 — Dec 2022 [monthly]

    Recruiting PHASE2

  3. Mar 2021 — Jun 2022 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universität Münster
  • medac GmbH
  • photonamic GmbH & Co. KG
Data source: Universität Münster

For direct contact, visit the study record on ClinicalTrials.gov .